Merger of Sanofi-Synthelabo and Aventis
bij 1 winkel
Verwant
Streepjescode: 9783638727211
Alle aanbiedingen
- bol.comMerger of Sanofi-Synthelabo and AventisNaar de winkel€ 26,99Op voorraad
We verdienen mogelijk commissie als je via deze link koopt. Wat jij betaalt verandert niet.
Over dit product
Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, grade: 80, Northumbria University (Newcastle Northumbria University), language: English, abstract: In the first part, this academic assignment provides general information about motives for international acquisitions. Moreover, it discusses whether foreign exchange markets and stock markets can be said to be efficient. The second part critically analyses the Merger of Sanofi-Synthélabo and Aventis by examining the following aspects:- market position of each company prior to the merger - motives for the proposed merger - attack and defence tactics applied by Sanofi-Synthélabo and Aventis - methods used to finance the merger- share price movements immediately before during and after the proposed take-over (commenting on the benefits to shareholders of each company)- company performance in the period following the take-over (reflecting on the initial take-over motives)
Omschrijving aangeleverd door bol.com.